Trial Profile
Efficacy of vonoprazan in patients with proton pump inhibitor-resistant reflux esophagitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2020
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Pharmacodynamics; Therapeutic Use
- 19 May 2020 Results (n=22) published in Gasteroenterology in conjunction with Digestive Disease Week 2020.
- 26 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017